Join us on the latest episode! Our Guests: Professor Omid Veiseh and Paul Cherukuri, Chief Innovation Officer at Rice University.

What you'll get out of this episode:

• The vision and strategies behind the Launchpad
• Houston as a key location for medical innovation
• Impact on the local and national biotech scene
• Upcoming projects and future prospects in biotechnology

To learn more about our guests and their companies:
Omid's LinkedIn: https://www.linkedin.com/in/omid-veiseh-0a545b3/
Paul's LinkedIn: https://www.linkedin.com/in/pcherukuri/
Website: https://www.rice.edu/
Company LinkedIn: https://www.linkedin.com/school/riceuniversity/

Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/

BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/

Join us on the latest episode! Our Guest: Katie Baca-Motes, Co-Founder And CSO At Scripps Research – Digital Trials And Engagement.

What you'll get out of this episode:

• The shift towards decentralized clinical trials.
• The impact of wearable technology on health monitoring.
• The role of patient-mediated Electronic Health Records (EHRs).
• Exploration of AI, wearables, and patient-centric data strategies.
• Katie Baca-Motes shares her perspectives on the advancements in digital healthcare.

To learn more about Katie and Scripps Research and Digital Trials and Engagement:
Guest LinkedIn: https://www.linkedin.com/in/katiebaca/
Website: https://digitaltrials.scripps.edu/
Company LinkedIn: https://www.linkedin.com/school/the-scripps-research-institute/

Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/

BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/

Join us on the latest episode! Our Guest: Greg Divis, CEO at Avadel Pharmaceuticals

What you'll get out of this episode:

• Discussing LUMRYZ, a new narcolepsy drug.
• Insights into the challenges of narcolepsy treatment.
• Avadel's future plans in healthcare innovation.

To learn more about Greg and Avadel Pharmaceuticals:
Guest LinkedIn: https://www.linkedin.com/in/greg-divis-a525334/
Website: https://www.avadel.com/
Company LinkedIn: https://www.linkedin.com/company/avadelpharmaceuticals/

Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/

BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/

Join us on the latest episode! Our Guest: Shankar Musunuri, Chairman, CEO and Co-Founder Ocugen

What you'll get out of this episode:

• Dr. Shankar Musunuri of Ocugen discusses gene and cell therapy innovations
• Focus on tackling unmet needs in ophthalmology and vaccine development
• Insights into Ocugen's unique platforms and global health impact
• Future prospects in biotech and healthcare advancements

To learn more about Ocugen:
Website: https://www.ocugen.com/
LinkedIn: https://www.linkedin.com/company/ocugen/

Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/

Join us on the latest episode! Our Guest: Jay Srinivasan, CEO of Truvian

What you'll get out of this episode:

• Discussing breakthroughs in healthcare diagnostics
• Insights on integrating technology in healthcare
• Truvian's mission: accessible and affordable healthcare
• Focus on early detection and intervention in medical testing
• Future vision for healthcare accessibility and efficiency

To learn more about Truvian: https://truvianhealth.com/

Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/

Join us on the latest episode! Our Guest: J.D. Mowery, CEO of KBI Biopharma

What you'll get out of this episode:

• Mowery's progression from the chemical industry to biopharma leadership.
• Exploration of Mowery's experiences in the industry.
• KBI BioPharma: Insights into the company's impact and role in the biopharmaceutical industry.
• Discussion on KBI BioPharma's international facilities and outreach.
• Mowery shares his strategic vision for KBI BioPharma and the evolving CDMO industry.
• A focus on the importance of customer relationships and collaborative approaches in biopharma.
• Mowery's thoughts on the future of biopharma and leadership.

To learn more about KBI Biopharma: https://www.kbibiopharma.com/

Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/

Join us on the latest episode! Our Guest: Raj Indupuri, CEO of eClinical Solutions

What you'll get out of this episode:

• Learn how AI optimizes clinical trial design and patient recruitment
• Explore the impact of AI on reducing drug development costs and timelines
• Understand the advancements toward personalized medicine
• Dive into the challenges and opportunities of adopting AI in life sciences
• Get insights on how other industries have successfully integrated AI and what healthcare can learn from them

To learn more about eClinical Solutions: https://www.eclinicalsol.com/

Our sponsors for this episode are:
Sage Growth Partners https://sage-growth.com/

Join us on the latest episode! Our Guest: Rafael Fantauzzi, Chief Diversity, Equity, and Inclusion Officer at Boehringer Ingelheim.

What you'll get out of this episode:

• Understanding DEI: Diversity, Equity, and Inclusion explained
•  Cultivating Inclusion: Building trust and embracing inclusive behaviors
• Collaborative Success: How collaboration fuels progress
• Staying Informed: The importance of keeping up with DEI trends and legal developments
• Future of DEI: Boehringer Ingelheim's vision for a more inclusive future

To learn more about Boehringer Ingelheim: http://www.boehringer-ingelheim.com

Our sponsors for this episode are:
Sage Growth Partners https://sage-growth.com/

Join us on the latest episode! Our Guest: Simon Allen, Former CEO, Anebulo Pharmaceuticals

What you'll get out of this episode:

• Journey from biochemistry to sell-side biotech business development.
• Current treatment landscape for ACI and the limitations therein.
• Introduction to ANEB-001, a promising antidote aimed at the CB1 receptor to counter cannabinoid overload.
• Impact of synthetic cannabinoids and the silent peril they pose.
• Upcoming milestones: Finalization of Phase 2 data and optimistic outlook towards FDA outcomes.

*Since the recording of this episode Simon has moved onto new endeavors*

To learn more about Anebulo Pharmaceuticals: https://www.anebulo.com/

Our sponsors for this episode are:
Sage Growth Partners https://sage-growth.com/

Join us on the latest episode! Our Guest: Dr. Helen Torley, President & CEO at Halozyme

What you'll get out of this episode:

• Introduction to Dr. Helen Torley, CEO and president of Halozyme.
• Halozyme's mission to reduce treatment burdens for patients.
• The revolutionary Enhanze technology: Transforming IV infusions to subcutaneous injections.
• The significant impact of Halozyme's innovations on healthcare systems.
• The power of partnerships in driving Halozyme's success.

To learn more about Halozyme: https://halozyme.com/

Our sponsors for this episode are:
Sage Growth Partners https://sage-growth.com/

#Halozyme #InnovationInHealthcare #DrugDelivery #BioBreakthroughs #PatientCare